Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Cancer Genetics Clinic is part of Stanford's Cancer Center, a National Cancer Institute-designated comprehensive cancer center offering genetic counseling and testing for individuals concerned with the risk of an inherited cancer predisposition. The clinic staff includes medical oncologists, genetic counselors, and geneticists.
The Stanford Cancer Center, Lucile Packard Children's Hospital, and the Stanford School of Medicine bring together a comprehensive, highly specialized team of board-certified doctors and certified genetic counselors dedicated to providing state-of-the-art cancer genetics information and tests. In addition to the clinical services offered, these specialists are constantly working on new discoveries and technologies in the laboratory to help better understand, treat, diagnose and screen persons at increased risk for hereditary cancers.
Part of the process of the Cancer Genetics program is to help you understand your condition and the screening and preventive options available to you. Our treatment recommendations are based on medical evidence (evidence-based medicine), up-to-date knowledge of hereditary cancers, new discoveries in the laboratory, and innovative clinical approaches.
James Ford, MD, director of the Stanford Cancer Genetics Program, has always been fascinated with figuring out how genetics influences cancer. His interest is in working with families to lower their risk of familial cancer.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.